Skip to content
10-Q

Quarterly Report

SANGAMO THERAPEUTICS, INC SGMO

0001628280-25-038860

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 301.71M sh
Shares Diluted Q2 2025 · Jun 30, 2025 256.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 238.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 203.95M sh
Shares Diluted Q2 2025 · Jun 30, 2024 194.05M sh
Capex Q2 2025 · Jun 30, 2025 $24K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$44.31M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$75.55M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $38.34M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $41.92M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $27.79M
Cash And Equivalents Q2 2025 · Dec 31, 2023 $45.2M
Stockholders Equity Q2 2025 · Jun 30, 2025 $19.6M
Stockholders Equity Q2 2025 · Mar 31, 2025 $4.91M
Stockholders Equity Q2 2025 · Dec 31, 2024 $22.77M
Stockholders Equity Q2 2025 · Jun 30, 2024 $23.69M
Stockholders Equity Q2 2025 · Mar 31, 2024 $56.7M
Stockholders Equity Q2 2025 · Dec 31, 2023 $82.89M
Current Liabilities Q2 2025 · Jun 30, 2025 $47.66M
Current Liabilities Q2 2025 · Dec 31, 2024 $45.81M
Total Liabilities Q2 2025 · Jun 30, 2025 $77.96M
Total Liabilities Q2 2025 · Dec 31, 2024 $78.87M
Current Assets Q2 2025 · Jun 30, 2025 $49.89M
Current Assets Q2 2025 · Dec 31, 2024 $51.69M
Total Assets Q2 2025 · Jun 30, 2025 $97.56M
Total Assets Q2 2025 · Dec 31, 2024 $101.64M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.08
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.44
Eps Basic Q2 2025 · Jun 30, 2025 −$0.08
Eps Basic Q2 2025 · Jun 30, 2025 −$0.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.18
Eps Basic Q2 2025 · Jun 30, 2024 −$0.44
Sga Expense Q2 2025 · Jun 30, 2025 $9.08M
Sga Expense Q2 2025 · Jun 30, 2025 $19.14M
Sga Expense Q2 2025 · Jun 30, 2024 $12.05M
Sga Expense Q2 2025 · Jun 30, 2024 $23.81M
Rd Expense Q2 2025 · Jun 30, 2025 $27.08M
Rd Expense Q2 2025 · Jun 30, 2025 $53.09M
Rd Expense Q2 2025 · Jun 30, 2024 $24.22M
Rd Expense Q2 2025 · Jun 30, 2024 $60.11M
Net Income Q2 2025 · Jun 30, 2025 −$19.99M
Net Income Q2 2025 · Jun 30, 2025 −$50.58M
Net Income Q2 2025 · Jun 30, 2024 −$36.13M
Net Income Q2 2025 · Jun 30, 2024 −$85.22M
Operating Income Q2 2025 · Jun 30, 2025 −$17.86M
Operating Income Q2 2025 · Jun 30, 2025 −$47.48M
Operating Income Q2 2025 · Jun 30, 2024 −$37.08M
Operating Income Q2 2025 · Jun 30, 2024 −$88.61M
Revenue Q2 2025 · Jun 30, 2025 $18.31M
Revenue Q2 2025 · Jun 30, 2025 $24.74M
Revenue Q2 2025 · Jun 30, 2024 $356K
Revenue Q2 2025 · Jun 30, 2024 $837K